Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
This pattern has created widespread confusion that deserves careful examination
Merck Enters into Exclusive Global License Agreement with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist December 18, 2024 6:45 am EST RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, today announced that they have entered into an exclusive global license agreement for HS-10535, an investigational preclinical oral small molecule GLP-1 receptor agonist
References Relevant literature includes work on BPC-157 (Sikiric P et al., Curr Pharm Des 2018
Mar-Apr 2020;2(2):218-221
The staffing problem is real
US$ 27.96
US$ 22.71
US$ 20.10
US$ 24.80
US$ 20.71
US$ 29.91
US$ 20.42
US$ 24.68
